Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension
Manuel J. Richter, Svenja Lena Tiede, Natascha Sommer, et al.
PLoS ONE (2016) Vol. 11, Iss. 11, pp. e0165982-e0165982
Open Access | Times Cited: 10

Showing 10 citing articles:

Cytokines as prognostic biomarkers in pulmonary arterial hypertension
Athénaïs Boucly, Ly Tu, Christophe Guignabert, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 3, pp. 2201232-2201232
Open Access | Times Cited: 29
Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders
Racheal G. Akwii, Constantinos M. Mikelis
Drugs (2021) Vol. 81, Iss. 15, pp. 1731-1749
Open Access | Times Cited: 22
Collagen 18A1/Endostatin Expression in the Progression of Right Ventricular Remodeling and Dysfunction in Pulmonary Arterial Hypertension
A.S. Ambade, Mario Naranjo, T. Tuhy, et al.
American Journal of Respiratory Cell and Molecular Biology (2024) Vol. 71, Iss. 3, pp. 343-355
Closed Access | Times Cited: 3
The Biological Bases of Group 2 Pulmonary Hypertension
Ana I. Fernández, Raquel Yotti, Ana González‐Mansilla, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5884-5884
Open Access | Times Cited: 24
An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
Joana Gomes, Inês Gandra, Rui Adão, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 14
Associations of Angiopoietins With Heart Failure Incidence and Severity
Brandon Peplinski, Brian A. Houston, David A. Bluemke, et al.
Journal of Cardiac Failure (2021) Vol. 27, Iss. 7, pp. 786-795
Open Access | Times Cited: 17
Association between cytokines and functional, hemodynamic parameters, and clinical outcomes in pulmonary arterial hypertension
Aditya A. Joshi, Ryan Davey, Youlan Rao, et al.
Pulmonary Circulation (2018) Vol. 8, Iss. 3, pp. 1-8
Open Access | Times Cited: 14
Update on pulmonary arterial hypertension research: proceedings from a meeting of experts
Vallerie V. McLaughlin, Matthew Bacchetta, David B. Badesch, et al.
Current Medical Research and Opinion (2017) Vol. 34, Iss. 2, pp. 263-273
Closed Access | Times Cited: 6
Beyond interleukin-6 in right ventricular function: Evidence for another biomarker
Manuel J. Richter, Hossein A. Ghofrani, Henning Gall
The Journal of Heart and Lung Transplantation (2017) Vol. 37, Iss. 5, pp. 674-675
Closed Access | Times Cited: 2
Targeting Vessel Formation in Pulmonary Arterial Hypertension: Is the Endostatin–Id1–Thrombospondin 1 Pathway a New Hope?
Christopher J. Rhodes
American Journal of Respiratory Cell and Molecular Biology (2020) Vol. 62, Iss. 4, pp. 411-412
Open Access | Times Cited: 1
Page 1

Scroll to top